VERONICA JENSEN: Open Payments
NPI 1700021391 · PISCATAWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 37 payments from 10 companies in 2025. Trend: 2023 $1,378 · 2024 $1,412 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $441 |
| ABBVIE INC. | 12 | $270 |
| Alkermes, Inc. | 2 | $98 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Teva Pharmaceuticals USA, Inc. | 3 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Lundbeck LLC | 2 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, LYBALVI, REXULTI, AUSTEDO XR, INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across NJ — which companies pay providers there.
